Bone marrow aspirate and biopsy revealed a markedly hypocellular marrow with no clusters of immature cells.
Her last bone marrow showed increased fibrosis, and overall cellularity of 5%.
good PO intake GU: no dysuria, hematuria GYN: post-menopausal; no discharge; normal PAP MSK: arthritis as above Neuro: no confusion, MS changes, weakness Skin: bruising to abdomen   Social History: MDS/aplastic anemia - [**1-6**] Nephrotic syndrome - [**2137**].
She responded well and has been off immunosuppressive agents since [**2140**]   Physical Exam: Vitals: T 98.3  BP 120/80  P 60  R 20  wt 63 kg, ht 63.25 in.
Her cyclosporin had been stopped for several days prior to transfer secondary to mental status changes.
An LP was performed on the day of transfer and she was started on meningitic doses on antibiotics acyclovir, aztreonam (instead of cephalasporin given that those may contribute to seizure activity), ampicillin, and vancomycin.
CSF cytology, EBV and CMV pcr, [**Male First Name (un) 2326**] virus, HSV PCR, cryto, toxo, EEE, and west [**Doctor First Name **] were also sent.
Once CSF cultures were negative for 48 hours, the ampicillin was stopped and the acyclovir was reduced to prophylactic doses.
Her MRI initially showed abnormal signal uptake, but was not present on her most recent MRI of [**11-19**].
She also sustained a small right subdural s/p fall, which remained stable over multiple MRI scans and CT scans.
She was discharged with prophylactic levofloxacin, acyclovir, and fluconazole, and will be coming in to have labs drawn over the weekend, including her FK506 trough levels.
Outpatient Physical Therapy Per PT protocol 15.
Disp:*30 syringes* Refills:*0*   Discharge Disposition: Home with Service  Discharge Diagnosis: Primary - Aplastic anemia/MDS s/p MUD  Secondary - s/p seizures (most likely secondary to cyclosporine toxicity), s/p nephrotic syndrome [**2137**], HTN   Discharge Condition: Good   Discharge Instructions: -please take all medications as prescribed below -follow up with all appointments -if symptoms of fevers/chills/sweats, seizures/increased tremors, weakness, instability, falls, and any other concerns arise, please return to the ED or see your PCP [**Name10 (NameIs) **] return tomorrow and sunday to have your labs drawn before seeing Dr. [**First Name (STitle) 1557**] on Monday.
DO NOT TAKE YOUR MORNING DOSE OF TACROLIMUS BEFORE YOU HAVE LABS DRAWN, YOU CAN TAKE THE TACROLIMUS AFTER THE LABS ARE DRAWN  Followup Instructions: Provider: [**Name10 (NameIs) **] [**Name11 (NameIs) 540**], MD Phone:[**Telephone/Fax (1) 44**] Date/Time:[**2142-12-25**] 2:30 ([**Hospital Ward Name 23**] 8) Provider: [**First Name11 (Name Pattern1) 1730**] [**Last Name (NamePattern4) 6175**], MD Phone:[**Telephone/Fax (1) 3237**] Date/Time:[**2142-12-3**] 12:30    Completed by:[**2142-12-1**
